Psychedelic Stocks,Shroom News Numinus Progresses Phase 1 Clinical Trial on Proprietary Psilocybin Product By Dennis Mutua October 21, 2021 Health care company focused on merging latest psychedelics medicine with best evidenced-based care and a holistic integrated approach to treating mental conditions Numinus Wellness Inc. (CVE: NUMI) announced having finished the st...
Featured,Trends & Articles UK PM Boris Johnson to Consider Calls to Decriminalize Psilocybin By Dennis Mutua October 21, 2021 The Prime Minister on UK, Boris Johnson says that he will consider the growing calls to decriminalize magic mushroom product commonly referred to as psilocybin in the country. Boris made these sentiments after Tory Member of Parli...
Featured,Shroom News COMPASS Pathways Secures UPTSO Patent for Crystalline Psilocybin By Dennis Mutua October 20, 2021 Mental healthcare company focusing on speeding patient access to evidence-based innovation in mental health COMPASS Pathways Plc. (NASDAQ: CMPS) announced having secured patent approval from United States Patent and Trademark Offi...
Spotlight Stock,Trends & Articles Cybin Completes 74th Pre-Clinical Study of Psychedelic Molecules By Dennis Mutua October 20, 2021 Life sciences company specializing on progressing psychedelic therapeutics by utilizing drug discovery platforms Cybin Inc. (NEO: CYBN) (NYSE American : CYBN) announced having completed its 74th preclinical study into psychedelic ...
Psychedelic Stocks,Shroom News Russell Peters to Have His First Psychedelic Experience With Red Light Holland By Dennis Mutua October 19, 2021 Psychedelic focused company specializing on production and sale of medical grade truffles Red Light Holland (CSE: TRIP) (OTC PINK: TRUFF) announced that its chief creative officer, Russell Peters, will be taking part in his first ...
Featured,Trends & Articles Nushama a New Psychedelics Wellness Center in New York Providing Ketamine Treatment By Dennis Mutua October 18, 2021 A newly established psychedelics wellness center in New York City, Nushama Psychedelic Wellness Center, is providing medically controlled treatments for patients suffering from chronic pain, anxiety, trauma-induced mood disorders ...
Psychedelic Stocks,Shroom News MindMed Joins Clinical Trials Transformation Initiative By Dennis Mutua October 15, 2021 Psychedelic medicine biotech company developing psychedelic-inspired medicine and therapies to treat addiction and mental conditions MindMed Inc. (NASDAQ: MNMD) (NEO: MMED) announced having joined Clinical Trials Transformation In...
Spotlight Stock,Trends & Articles Levitee Labs Appoints Dr. Mohammed Mosli as Chief People Officer in the Company By Dennis Mutua October 15, 2021 Emerging integrative wellness company focusing on changing traditional mental healthcare and addictions trough use of psychedelics Levitee Labs Inc. (CSE: LVT) (OTCPINK: LVTTF) announced having appointed Dr. Mohammed H. Mosli the ...